News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Merck & Co., Inc. Announces Second Quarter 2011 Financial Results
July 29, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2011.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Merck & Co.
MORE ON THIS TOPIC
IPO tracker
Odyssey tests IPO waters anew after quitting quest last year
April 20, 2026
·
10 min read
·
Tristan Manalac
Layoff Tracker
BMS layoffs hits Lawrenceville hard, adding 200+ to cut count
April 20, 2026
·
49 min read
·
BioSpace Editorial Staff
GLP-1
Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch
April 17, 2026
·
1 min read
·
Tristan Manalac
IPO
UPDATE: Kailera breaks biotech IPO record with $625M debut
April 17, 2026
·
4 min read
·
Tristan Manalac